Author:
Arafat A. M.,Möhlig M.,Weickert M. O.,Schöfl C.,Spranger J.,Pfeiffer A. F. H.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference50 articles.
1. Simpson H, Savine R, Sonksen P et al (2002) Growth hormone replacement therapy for adults: into the new millennium. Growth Horm IGF Res 12:1–33
2. Tomlinson JW, Holden N, Hills RK et al (2001) Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 357:425–431
3. Erfurth EM, Bulow B, Eskilsson J, Hagmar L (1999) High incidence of cardiovascular disease and increased prevalence of cardiovascular risk factors in women with hypopituitarism not receiving growth hormone treatment: preliminary results. Growth Horm IGF Res 9(Suppl A):21–24
4. Rosenfalck AM, Fisker S, Hilsted J et al (1999) The effect of the deterioration of insulin sensitivity on beta-cell function in growth-hormone-deficient adults following 4-month growth hormone replacement therapy. Growth Horm IGF Res 9:96–105
5. Weaver JU, Monson JP, Noonan K et al (1995) The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults. J Clin Endocrinol Metab 80:153–159
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献